OKYO Pharma Limited (OKYO) Financials

OKYO Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2025 4.6 million 8.1 million
June 30, 2025 3.7 million 9.2 million
March 31, 2025 3.7 million 9.2 million
Dec. 31, 2024 3.7 million 9.2 million

OKYO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2025 -1.5 million ?
June 30, 2025 -1.6 million ?
March 31, 2025 -1.6 million 622
Dec. 31, 2024 -785 622

OKYO Net Income

No data available :(

OKYO Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2025 4.2 million - -
June 30, 2025 1.6 million - -
March 31, 2025 1.6 million - -
Dec. 31, 2024 1.6 million - -

OKYO Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2025 37.4 million
June 30, 2025 36.0 million
March 31, 2025 39.5 million
Dec. 31, 2024 45403

OKYO Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2025 3 -44050 2.8 million -
June 30, 2025 1203 38371 - -
March 31, 2025 1203 38371 4.1 million -
Dec. 31, 2024 - 19 - -

OKYO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2025 - 885
June 30, 2025 - 1289
March 31, 2025 - 1289
Dec. 31, 2024 - 1857

OKYO

Price: $1.54

52 week price:
1.34
3.35

Earnings Per Share: -0.11 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 65.6 million

Links: